Articles
New Drug Testing Program From AMO Employer Services Targets Patients In Long Term Care Facilities
January 28, 2010
New Patient Drug Testing Program Offered by AMO Employer Services Verifies That Patients in Long Term Care Facilities Get Proper Prescriptions. It Prevents Unnecessary Patient Suffering, Toxic Drug Combinations and Prescription Diversion.
Washington, MO (PRWEB) - A new division of AMO Employer Services has discovered a way to utilize advances in oral fluid drug testing technology to help long term care facilities verify that patients are receiving their prescribed medications in a dignified and painless fashion. Patient drug testing has become the newest way of making sure that nursing home residents are being protected from the consequences of improper or incomplete prescription administration.
In an effort to maximize the quality of care they provide and limit their liabilities, savvy healthcare providers are now looking at patient drug testing programs to fill voids in the flawed processes that have allowed unnecessary patient suffering and deaths to occur. For patients, family members and healthcare providers, this method of improving patient care is a welcome relief.
The Access Safety Program is offered as a way to make sure that caregivers are more interested in providing pain relief to their patients than they are in supplementing their income by selling stolen prescriptions according to Rick Wassman, senior vice president of the St. Louis based company which promotes this program at www.PrivacyDignitySafety.com. "In the past, it was hard to get the people responsible for stealing the drugs, using the drugs, or making mistakes to quit or admit their wrongdoing, and now there is proof," says Wassman.
Additional details regarding the Access Safety Program are available at http://www.PrivacyDignitySafety.com or by calling the Reverse Risk Consulting Division of AMO-Employer Services at 314-414-8845.
Note to editors and news directors: Wassman available for interview
SOURCE: PRWeb
View original release here: http://www.prweb.com/releases/2010/01/prweb3466254.htm

